ACRO BIOMEDICAL CO., LTD. Deferred Income Tax Expense (Benefit)
ACRO BIOMEDICAL CO., LTD. (ACBM) reported Deferred Income Tax Expense (Benefit) of -$9.87 thousand for the 9-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2019-08-14
- ACRO BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for the quarter ending 2019-06-30 was $55.19K.
- ACRO BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for the quarter ending 2019-03-31 was -$45.12K.
- ACRO BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for the quarter ending 2018-12-31 was -$19.94K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month |
|---|---|---|---|
| 2019-06-30 | $55.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $10.07K derived: sum of 2 quarters · filed 2019-08-14 | -$9.87K 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$45.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | -$65.06K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$19.94K 10-Q · filed 2019-02-14 |